Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL

Completed · Phase 1

Conditions studied: Diffuse Large B-cell Lymphoma

In brief

This is an open-label, randomized, multicentre study to evaluate safety and preliminary efficacy of the human anti-CD19 antibody Tafasitamab in addition to R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) or Tafasitamab and Lenalidomide in addition to R-CHOP in adult patients with newly diagnosed, previously untreated Diffuse Large B-cell Lymphoma (DLBCL).

Key facts

Study ID

NCT04134936

Run by

MorphoSys AG

People needed

66

Starts

2019-12-11

Expected to finish

2022-08-10

Last updated by the study team

2024-10-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• MorphoSys Research Site — Anaheim, California, United States
• MorphoSys Research Site — Duarte, California, United States
• MorphoSys Research Site — Encinitas, California, United States
• MorphoSys Research Site — Aurora, Colorado, United States
• MorphoSys Research Site — New Haven, Connecticut, United States
• MorphoSys Research Site — Washington D.C., District of Columbia, United States
• MorphoSys Research Site — Urbana, Illinois, United States
• MorphoSys Research Site — Louisville, Kentucky, United States
• MorphoSys Research Site — Covington, Louisiana, United States
• MorphoSys Research Site — Rockville, Maryland, United States
• MorphoSys Research Site — Ann Arbor, Michigan, United States
• MorphoSys Research Site — Rochester, Minnesota, United States
• MorphoSys Research Site — Cincinnati, Ohio, United States
• MorphoSys Research Site — Cleveland, Ohio, United States
• MorphoSys Research Site — Eugene, Oregon, United States
• MorphoSys Research Site — Charleston, South Carolina, United States
• MorphoSys Research Site — Austin, Texas, United States
• MorphoSys Research Site — Dallas, Texas, United States
• MorphoSys Research Site — Houston, Texas, United States
• MorphoSys Research Site — San Antonio, Texas, United States
• MorphoSys Research Site — Tyler, Texas, United States
• MorphoSys Research Site — Vancouver, Washington, United States
• MorphoSys Research Site — Graz, Austria
• MorphoSys Research Site — Innsbruck, Austria
• MorphoSys Research Site — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.